BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37405957)

  • 21. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitin-specific protease 15 contributes to gastric cancer progression by regulating the Wnt/β-catenin signaling pathway.
    Zhong M; Zhou L; Fang Z; Yao YY; Zou JP; Xiong JP; Xiang XJ; Deng J
    World J Gastroenterol; 2021 Jul; 27(26):4221-4235. PubMed ID: 34326621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
    Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA BE503655 inhibits osteosarcoma cell proliferation, invasion/migration via Wnt/β-catenin pathway.
    Huang Q; Shi SY; Ji HB; Xing SX
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31316000
    [No Abstract]   [Full Text] [Related]  

  • 27. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
    Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
    J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carboxypeptidase E-ΔN promotes migration, invasiveness, and epithelial-mesenchymal transition of human osteosarcoma cells via the Wnt-β-catenin pathway.
    Fan S; Gao X; Chen P; Li X
    Biochem Cell Biol; 2019 Aug; 97(4):446-453. PubMed ID: 30508384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathway.
    Tian H; Zhou T; Chen H; Li C; Jiang Z; Lao L; Kahn SA; Duarte MEL; Zhao J; Daubs MD; Buser Z; Brochmann EJ; Wang JC; Murray SS
    J Orthop Res; 2019 Jul; 37(7):1638-1648. PubMed ID: 30737824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration.
    Han GD; Dai J; Hui HX; Zhu J
    J Orthop Surg Res; 2023 Jun; 18(1):446. PubMed ID: 37344882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
    He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
    J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
    J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 36. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Feng P; Zhu L; Jie J; Yang P; Sheng N; Chen X; Chen X
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3587-3598. PubMed ID: 35960375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Zhang QH; Hu QX; Xie D; Chang B; Miao HG; Wang YG; Liu DZ; Li XD
    Integr Cancer Ther; 2019; 18():1534735419890917. PubMed ID: 31855073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.